Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporin A for prevention and treatment of recurrent spontaneous abortion
ChiCTR-TRC-14004216Phase 4Completed
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Aug 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cyclosporine and dydrogesterone in recurrent miscarriage (RPL) (3 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoints: Ultrasound image, Liver function tests and 4 more. Started Aug 2012; status: completed.
02
Drugs
cyclosporinedydrogesterone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ChiCTR-TRC-14004216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004216.